Skip to content

Clinical trial of exercise intervention to improve diabetes mellitus

Clinical trial of exercise intervention to improve diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066710
Enrollment
Unknown
Registered
2022-12-14
Start date
2022-12-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

High body fitness group :Individualized exercise prescription
Middle body fitness Group :Individualized exercise prescription
Low body fitness group:Individualized exercise prescription

Sponsors

Yangpu Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age: 18-80 years old; (2) Patients who meet the diagnostic criteria of diabetes and are clinically classified as type 2 diabetes; According to the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition), patients with the following characteristics can be diagnosed with diabetes : ? Typical diabetes symptoms (including polydipsia, polydipsia, polyuria, polydipsia, weight loss); ? Random blood glucose =11.1mmol/L or fasting blood glucose =7.0mmol/L or OGTT2h blood glucose =11.1mmol/L or HbA1c=6.5%. Note: If there is no ? typical symptoms of diabetes, we need to check again on another day to confirm ?. (3) Agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Type 1 diabetes mellitus or other special type diabetes mellitus; (2) Diabetic patients with acute complications of diabetes or poor blood glucose control: HbA1c > 9.5%; (3) Patients with severe chronic complications of diabetes (severe diabetic nephropathy, severe neuropathy, severe diabetic retinopathy, diabetic foot and lower limb artery occlusion); (4) Complicated with severe cardiovascular and cerebrovascular diseases, including myocardial infarction, congestive heart failure, severe arrhythmia, non-stable cerebrovascular accident, postural hypotension, etc.; (5) Unstable hypertension control =160/100mmHg; (6) Patients with other history of critical illness; Including severe liver disease, severe kidney disease, severe lung disease, lupus erythematosus, etc. (7) Life expectancy not more than 5 years (complicated with malignant tumor and poorly controlled disease); (8) Female subjects who are pregnant or plan to become pregnant within the next 12 weeks; (9) It is not expected to complete the intervention with other conditions; (10) Participated in other clinical trials within the last 4 weeks; (11) Unable to complete exercise or for other reasons, the researcher thinks it is not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Glycosylated hemoglobin;Fasting blood glucose;Physical fitness assessment;TIR;

Secondary

MeasureTime frame
Imageological examination;blood lipids;

Countries

China

Contacts

Public ContactCheng Wei

Yangpu Hospital Affiliated to Tongji University

zhou824@sina.com13761562522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026